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Humans are exposed, orally, to vast 
numbers of nonbiological nanoparticles 
and microparticles, many of which are 
chemically persistent. Within this category, 
the ingestion of silicates and food grade 
titanium dioxide (fgTiO2) is estimated at 
37.5  mg (median), or 1012–1013 particles, 
per adult per day in the UK.[1] For fgTiO2, 
this equates to an intake of ≈0.04 mg kg−1 
body weight per day for a 70 kg adult.[1] A 
further carefully conducted study reported 
broadly similar results in the Netherlands 
(0.06–0.17 mg kg−1 body weight per day at 
>7 years of age), with even higher fgTiO2 
intakes recorded for children of 2–6 years 
of age.[2]
What the effects of exposure are to 
these or other particles, via the oral route, 
is unknown but has become a key agenda 
item for the relevant regulatory bodies.[3–9]
With this in mind, this issue’s focus on 
“rethinking nanosafety” is timely. This is 
especially so, given that accumulated data 
Human exposure to persistent, nonbiological nanoparticles and 
microparticles via the oral route is continuous and large scale 
(1012–1013 particles per day per adult in Europe). Whether this matters or 
not is unknown but confirmed health risks with airborne particle exposure 
warns against complacency. Murine models of oral exposure will help to 
identify risk but, to date, lack validation or relevance to humans. This work 
addresses that gap. It reports i) on a murine diet, modified with differing 
concentrations of the common dietary particle, food grade titanium dioxide 
(fgTiO2), an additive of polydisperse form that contains micro- and nano-
particles, ii) that these diets deliver particles to basal cells of intestinal 
lymphoid follicles, exactly as is reported as a “normal occurrence” in 
humans, iii) that confocal reflectance microscopy is the method of analytical 
choice to determine this, and iv) that food intake, weight gain, and Peyer’s 
patch immune cell profiles, up to 18 weeks of feeding, do not differ between 
fgTiO2-fed groups or controls. These findings afford a human-relevant and 
validated oral dosing protocol for fgTiO2 risk assessment as well as provide 
a generalized platform for application to oral exposure studies with nano- 
and micro-particles.
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now show real and definitive health risks as a result of our 
exposure to common environmental particulates.[10] Notably, 
the relationship between airborne particles and cardiopul-
monary diseases has been consistently demonstrated. How-
ever, much of this research has relied upon epidemiological 
approaches whereby large populations under different exposure 
conditions are correlated against adverse outcomes (i.e., mor-
tality or biomarkers of disease).[11,12] To understand the risk of 
oral exposures to common particles, however, such approaches 
are limited. This is because while exposures undoubtedly vary 
across populations, they do so in a diffuse fashion and not in 
geographical subpopulations. Data, therefore, are difficult to 
capture: dietary intake measures are reasonably crude and, 
unless specifically designed, do not include intakes of pharma-
ceuticals, nutraceuticals, or swallowed toothpastes, which are 
major sources of oral particle intakes.[1] Even when studies are 
specifically designed to track all sources of oral particle expo-
sure to humans, the complexity is such that subject numbers 
are limited by practicable design.[1] Moreover, oral intake studies 
do not track long-term exposures, but provide information on a 
short window of a few days or a week.
Distinct methodology is therefore required for the oral route 
and, likely, an aggregate of approaches, including carefully 
conducted murine studies, will be necessary to inform human 
health risk assessment, effectively.
Recently, the pitfalls of murine oral exposure models for 
nanoparticle and microparticle research have been reviewed.[13] 
In particular, it was noted that real-world human exposures 
are poorly represented by gavage whereby concentrated, daily 
boluses are forced into the stomach of rodents via an oral tube. 
Aside from physiological stress and its effects on the intestine, 
particles have a tendency to agglomerate and aggregate when 
concentrated. This may occur in the dosing apparatus, or in the 
intestine itself but, importantly, it may be irreversible resulting 
in no or limited uptake from the intestine. In any case, bolus 
delivery does not reflect human exposure patterns to parti-
cles, which will trickle in throughout the day from the acts of 
brushing teeth, through to intakes of diet and pills, to brushing 
of the teeth again. Usefully, rodents tend to graze on their diet 
providing a model to mimic the nature of human exposure 
to particles. Any criticism that dietary intakes are variable in 
rodents, and cannot be precisely monitored, can be readily 
countered by the arguments above, which outline much greater 
problems with the alternatives. Moreover, Organisation for Eco-
nomic Co-operation and Development (OECD) guidelines for 
repeat dose oral toxicity testing (e.g., TG 408)[14] do not mandate 
gavage but also allow for a test material to be incorporated in 
the diet or dissolved in drinking water, so any dietary approach 
could still be adopted within the OECD framework.
The next aspect for consideration is whether particle 
absorption from the small intestine via the murine diet 
“vehicle” is successfully achieved. Indeed, the importance of 
confirming particle uptake for proper in vitro hazard identifi-
cation, and avoidance of false-negative outcomes, has been a 
topic of considerable focus in recent years.[15–17] In much the 
same way, this same logic must apply to in vivo experimen-
tation and, especially so, when human precedence has been 
so clearly demonstrated. In humans, the known target tis-
sues for orally ingested, persistent particulates are the large 
lymphoid follicles of the small intestine, typically referred to 
as Peyer’s patches. Repeatedly, these have been shown to con-
tain basally located “pigment cells” that accumulate, nano- and 
micro-particles including a marked proportion of fgTiO2.[18–23] 
It is beyond reasonable doubt that these particles accumu-
late in such cells as a result of the “every day” oral exposures 
described above. By no means does this rule out other tissue 
sites for environmental particle accumulation in humans, and, 
indeed, this is known to occur for liver and spleen.[24] How-
ever, as of yet, no other sites have been so thoroughly studied, 
or the precise location of their particle accumulating cells so 
accurately pin-pointed, as for Peyer’s patches. In turn, if, a diet 
with added persistent particles is to be considered a successful 
mimic of regular human exposures then basal Peyer’s patch 
accumulation of the fed particles must be observed.
Here, we develop diets incorporating three differing levels 
of fgTiO2 to permit a physiologically relevant exposure method. 
We then confirm that these diets act as suitable “delivery vehi-
cles.” We achieve this, for the first time in a murine model, by 
assessing the formation of particle-loaded cells at the base of 
gut lymphoid follicles (Peyer’s patches) as occurs in humans. 
Finally, we also establish sex-specific, key baseline measures 
such as intakes of fgTiO2 as a result of the dosing regimen, 
animal weight gain, and how immune cell fractions of the 
Peyer’s patch change at three different time points under con-
firmed exposure; all referenced to a negative control group (i.e., 
same diet but no fgTiO2 supplementation).
The diets were constructed through incorporation of fgTiO2 
into the basal diet, namely American Institute of Nutrition 
(AIN)-76A, by “Research Diets, Inc.” (USA). The primary 
particle size distribution of the fgTiO2 has been described 
previously.[25] Scanning electron microscopy (SEM) and energy 
dispersive X-ray (EDX) spectroscopy confirmed that the particu-
late nature of the fgTiO2 was retained after diet incorporation 
(Figure S1, Supporting Information).
To validate whether the diets permitted uptake from the 
intestinal lumen, and thus cellular exposures to the fgTiO2, 
we surveyed the basal regions (i.e., serosal aspect) of Peyer’s 
patches for fgTiO2-containing cells at the end of the feeding 
study (18 weeks). The tissue harvest and method used to pre-
pare sections—being careful to avoid inadvertent contamina-
tion—are shown in Figure  S2 (Supporting Information). This 
time point was chosen on the basis that the cellular accumula-
tion of particles, deep in tissues, will require time and, pragmat-
ically, because the goal was simply to assess whether the diet 
had achieved successful particle delivery or not. To achieve this, 
reflectance confocal microscopy, as previously used in human 
tissue analyses, was employed to detect the presence of fgTiO2 
(Figure 1).[21] A robust threshold for the detection of reflectant foci 
consistent with fgTiO2 was defined by removing all signal from 
complete, tile scanned images of Peyer’s patch tissue sections 
taken from three negative control animals (Figure  1A). Reflec-
tant foci, indicating the presence of fgTiO2, were found at the 
base of Peyer’s patches for all three dose groups (Figure 1C–E) 
(additional “Z-stack” 3D images also shown in Figure  S3 in 
the Supporting Information). As previously shown in humans, 
SEM/EDX analyses confirmed that the tissue contained subsur-
face particles rich in titanium (Figure 1F–H), further validating 
the reflectance findings.
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Figure 1. Accumulation of fgTiO2 in basal cells of murine Peyer’s patches following feeding. A) Tile scanned “overview” image of a typical murine ileal 
tissue section containing a Peyer’s patch lymphoid follicle. Cell nuclei are labeled in blue by the fluorescent dye Hoechst 33342. The “base” region of 
the patch, which lies just above the muscularis layer, is indicated (yellow). The example shown is from an unexposed mouse. Tissues from B) negative 
control and C–E) fgTiO2-exposed mice: Inset are boxed regions at higher magnification. Confocal reflectance microscopy (0.8 µm optical sections taken 
from the center of tissue sections) reveals the increasing formation of particle-loaded cells when mice are fed diets containing increasing amounts 
C–E) of fgTiO2 (red circle markers placed on reflectance signal to aid visualisation). F–H) Imaging and physical analysis by scanning electron microscopy 
and energy dispersive X-ray analysis H) confirms the presence of titanium-rich particles inside of the tissue sections taken from the fgTiO2-fed mice. 
B–E) Scale bars = 25 µm, with 10 µm in zoomed insets. F–H) Scale bars = 10 µm.
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Interestingly, the low and medium diets (6.25 and 62.5 mg 
fgTiO2 kg−1 diet) only generated very lightly impacted cells at 
the base of the Peyer’s patch, whereas the high diet (625 mg 
fgTiO2 kg−1 diet) generated something akin to “precursor 
pigment cells” (Figure 1B–E). These latter findings were much 
more reminiscent of the cellular fgTiO2 loading previously 
observed in humans in this tissue region.[18–23]
Throughout the feeding, the mice appeared healthy and 
weight gains were, as expected, different between female and 
male mice within each diet group, but there was no difference 
between the diet groups (Figure  2). Overall, from these data 
we could estimate that mice were, on average, each exposed to 
≈17 µg (low), 165 µg (medium), and 1672 µg (high) of fgTiO2 
per day (Table 1). Titanium dioxide was not present in the base-
line diet of the control group.
In the flow cytometry-based analyses of digested Peyer’s 
patch cell suspensions (Figures S4 and S5, Supporting Infor-
mation), at different time points, repeated-measures analysis of 
variance (ANOVA) demonstrated an effect of time on the mean 
live phagocyte gate (P  < 0.0001), with significant differences 
between week 6 and week 12 and between week 6 and week 
18 (Figure  3). However, there was no influence of sex or diet 
(P > 0.6) on the percentages of live phagocytes. There was also 
no significant effect of time, sex, or diet on the live lympho-
cytes (P > 0.2). For the subpopulations of cells, i.e., CD4 or CD8 
T cells, B cells, or different phagocytes (CD11b/CD11c/double 
negative), the cell marker percentages were reliably consistent 
between groups (Figures S6 and S7, Supporting Information). 
CD8α CD11chigh dendritic cells are renowned for the cross-pres-
entation of exogenous antigen and stimulation of CD8+ T-cell 
responses.[26] Phenotypic analyses of the phagocytic population 
present in the Peyer’s patches whole digests were extended to 
examine CD8α  and CD11b expression on CD11chigh subsets. 
This also failed to demonstrate any indication of the promotion 
of proinflammatory innate immune cell subsets resulting from 
the fgTiO2 diet (Figure  S8 and Tables S1 and S2, Supporting 
Information). The findings show, therefore, that long-term 
feeding of fgTiO2 does not affect immune cell populations of 
the Peyer’s patch, despite additionally confirming this to be a 
site of uptake and basal accumulation for the particles. More 
detailed analyses can now be undertaken in future work and 
outcomes in Peyer’s patches linked to particle exposure, rather 
than some indirect effect of cell recruitment or migration.
In summary, in contrast to current mainstream work, this 
study demonstrates that incorporation of fgTiO2 into the AIN-
76A diet permits uptake and subsequent delivery of fgTiO2 to 
target sites of known human relevance, which is a significant 
advancement for enabling oral particle risk assessment. Impor-
tantly, diets as high as ≈100 mg kg−1 body weight per day can 
be delivered via normal feeding without any evidence of gross 
perturbation of immune-cell physiology. We also demonstrate 
how simple reflectance microscopy of forming pigmented cells 
at the base of Peyer’s patches can be used to validate successful 
exposure. In the view of the authors, this kind of validation 
should become an essential component for in vivo studies with 
fgTiO2. For example, a recent study where growing rats were 
fed a pelleted diet containing ≈40, 400, or 5000 mg fgTiO2 kg−1 
diet, and then a large range of analyses undertaken, provided 
no information to confirm that tissues were actually exposed in 
the study.[27] This makes the suite of “no effect outcomes” that 
were reported difficult to interpret.
The reporting of persistent particles, including titanium 
dioxide, associating with Peyer’s patches in murine experi-
ments is not new. However, prior studies bear no relation to the 
advances reported here. For example, following oral gavage with 
large TiO2 particles (475 ± 24 nm), Jani et al. report an implau-
sible tissue uptake of 11.9% and, with electron microscopy, they 
show a particle “in the vicinity of a Peyer’s patch” with some 
apparently also noted in the “granular areas.”[28] Bettini et  al. 
report analytical signals that are suggestive of titanium dioxide 
somewhere in the murine Peyer’s patch after addition of the 
particles to drinking water.[29] Again, in the context of orally 
dosed titanium dioxide, Warheit et al. mention Peyer’s patches 
in a table.[30] The work that we present is entirely different in 
that it tracks properly-fed fgTiO2 into specific cell sites, namely 
the base of the Peyer’s patch, exactly as is seen in humans. 
Furthermore, we demonstrate how this is measurable with 
a simple light microscopy technique, yielding a readily acces-
sible, site-specific “biomarker” that can be used to confirm suc-
cessful uptake and cell exposure after feeding.
In short, the diet and methodology presented here provide 
for a physiologically relevant, oral dosing approach in particle 
risk assessment with appropriate tissue exposure measures. It 
will allow much more detailed analyses of the potential effects 
of fgTiO2 to now be undertaken, with proper human relevance, 
and should serve as a base for any such nanoparticle or micro-
particle research that is interested in the physiological and long-
term dosing of persistent particles. Moreover, as noted above, 
this approach can be readily adopted within the OECD frame-
work for next-generation risk assessments. For example, it is 
known that human cells are impacted by fgTiO2, and accumula-
tion increases with age. Further steps would be a careful assess-
ment of toxicity potential in a tissue-relevant fashion. Indeed, 
Peyer’s patches are key structures in intestinal immunosur-
veillance and in the generation of immune responses, notably 
involving immunoglobulin A. How human-relevant exposure 
to fgTiO2 impacts such functionality can now be addressed, 
beyond our current knowledge that gross perturbation of 
the system (cell infiltration) does not occur. In addition, how 
mesenteric lymph nodes are impacted by oral fgTiO2 can also 
now be investigated, alongside the implications for gastrointes-
tinal immune responses.
Experimental Section
The study procedures described were approved by the Grasslands Animal 
Ethics Committee (Palmerston North, New Zealand) in accordance with 
the New Zealand Animal Welfare Act 1999. The fgTiO2 was obtained 
from Sensient Colors (St. Louis, MO, USA). C57BL/6 mice aged 6 weeks 
were randomly assigned to one of four diets (0, 6.25, 62.5, or 625 mg 
fgTiO2 kg−1 of diet) exposing the mice to, respectively, 0 and ≈1, 10, and 
100 mg fgTiO2 kg−1 body weight per day. Mice were housed conventionally 
with feed intake and body weight recorded biweekly. At 6, 12, and 
18 weeks, mice were euthanized and the gastrointestinal tracts harvested. 
Ileal tissues containing the most distal Peyer’s patch were excised and 
snap frozen. Those from 18 weeks feeding were examined via confocal 
microscopy and SEM with EDX analysis. Remaining Peyer’s patches were 
collected and enzymatically digested to form single-cell suspensions 
for flow cytometry analysis after staining with either lymphocyte 
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Figure 2. Body weights of wild-type C57BL/6 mice fed with AIN-76A diet ± fgTiO2 at three levels. Body weights were recorded twice weekly for male 
(M: green) and female (F: blue) mice over A) 6 weeks, B) 12 weeks, or C) 18 weeks. Means ± standard error of the mean (SEM) are shown (n = 6 M and 6 F). 
** P ≦ 0.01 male versus female body weights (one-way ANOVA with initial body weight used as a covariate).
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(CD4, CD45R, and CD8a) or myeloid (CD11b, CD11c, and CD8a) antibody 
staining cocktails with propidium iodide (PI) for dead cell exclusion.
For confocal microscopy and SEM–EDX, frozen ileal tissue was 
embedded and 25 µm thick cryostat sections cut and collected on slides. 
Nuclei were labeled using Hoechst 33 342 and slides were mounted with 
Prolong Diamond mountant. Reflectance confocal microscopy images 
were obtained using a Leica SP8 confocal microscope equipped with a 
40×/1.3 oil immersion objective. A 405 nm laser was used for Hoechst 
Small 2020, 2000486
Figure 3. Frequencies of live cells residing within phagocyte and lymphocyte flow cytometric cell gates. Flow cytometric analysis of filtered, propidium 
iodide (PI)-stained single-cell suspensions derived from Peyer’s patch tissues of mice fed the AIN-76A diet, with or without added fgTiO2, for 6, 12, 
or 18 weeks. Control, low, medium, and high titanium dioxide diets refer to the amount of fgTiO2 added to the basal diet as defined in the text. The 
mean ± SEM percentages of live (PI negative) cells residing within the A) phagocyte or B) lymphocyte gates are shown; (n = 6–8). Full flow cytometry 
gating and analysis strategy and a further breakdown of cell phenotype are shown in the Supporting Information. No significant differences were found 
between any of the diets for the combined (n = 6–8), male (n = 3–4), or female (n = 3–4) groups.
Table 1. Mean daily TiO2 intake and daily TiO2 dose of wild-type mice fed with the AIN-76A TiO2 containing diet.
Daily TiO2 intake [mg day−1]
Sex Diet 6 weeks 12 weeks 18 weeks P valuea)
Female 6.25 0.016 ± 0.002 0.016 ± 0.001 0.016 ± 0.001 0.89
62.5 0.162 ± 0.008 0.154 ± 0.012 0.161 ± 0.012 0.41
625 1.621 ± 0.126 1.569 ± 0.087 1.543 ± 0.081 0.32
Daily TiO2 dose [mg kg−1 body weight]
6.25 0.897 ± 0.071** 0.825 ± 0.084** 0.759 ± 0.029** <0.05b)
62.5 8.737 ± 0.365* 7.730 ± 0.552* 7.931 ± 0.620* <0.05b)
625 88.027 ± 6.886** 79.451 ± 6.708** 71.827 ± 4.640** <0.01b)
Daily TiO2 intake [mg day−1]
Male 6.25 0.017 ± 0.001 0.018 ± 0.002 0.018 ± 0.002 0.34
62.5 0.176 ± 0.018 0.172 ± 0.005 0.166 ± 0.007 0.38
625 1.783 ± 0.133 1.750 ± 0.102 1.768 ± 0.145 0.98
Daily TiO2 dose [mg kg−1 body weight]
6.25 0.763 ± 0.049 0.737 ± 0.065 0.682 ± 0.076 0.11
62.5 7.586 ± 0.990 6.965 ± 0.402 6.876 ± 0.516 0.24
625 76.827 ± 4.700*** 70.853 ± 5.564*** 63.335 ± 4.933*** <0.05b)
a)Statistical comparison with one way ANOVA; b)Pairwise comparison of group means with Tukey’s honestly significant difference test; significant differences between 
groups with superscript letters *P < 0.05, **P ≤ 0.01, and ***P < 0.001.
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33  342 excitation. On a second sequence, reflectance from a 488 nm 
laser was used to detect the fgTiO2. As noted in the text for results and 
discussion, a robust threshold for the detection of fgTiO2 was made by 
removing all signals from tile scanned images collected from negative 
control mice (i.e., exposed to the base diet but not fgTiO2). A red circle 
marker was placed on each reflectance pixel above the threshold using 
the inbuilt “insertShape” function in MATLAB R2019b (MathWorks). 
After confocal microscopy, cover slips were removed and the slides 
dried, cut down, mounted on stubs using colloidal graphite, and lightly 
sputter-coated with carbon for SEM/EDX of Peyer’s patch regions. A 
description of the statistical analyses and further details of methods can 
be found in the Supporting Information.
Supporting Information
Supporting Information is available from the Wiley Online Library or 
from the author.
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